000 | 01830 a2200529 4500 | ||
---|---|---|---|
005 | 20250514003951.0 | ||
264 | 0 | _c20010823 | |
008 | 200108s 0 0 eng d | ||
022 | _a0022-3042 | ||
024 | 7 |
_a10.1046/j.1471-4159.2001.00386.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLipsky, R H | |
245 | 0 | 0 |
_aNuclear factor kappaB is a critical determinant in N-methyl-D-aspartate receptor-mediated neuroprotection. _h[electronic resource] |
260 |
_bJournal of neurochemistry _cJul 2001 |
||
300 |
_a254-64 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S. | ||
650 | 0 | 4 |
_a5' Untranslated Regions _xgenetics |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aBase Sequence |
650 | 0 | 4 | _aBinding Sites |
650 | 0 | 4 |
_aBrain-Derived Neurotrophic Factor _xgenetics |
650 | 0 | 4 |
_aCell Nucleus _xmetabolism |
650 | 0 | 4 |
_aCerebellum _xcytology |
650 | 0 | 4 |
_aCytoplasm _xmetabolism |
650 | 0 | 4 |
_aDNA-Binding Proteins _xmetabolism |
650 | 0 | 4 |
_aDizocilpine Maleate _xpharmacology |
650 | 0 | 4 | _aExons |
650 | 0 | 4 | _aI-kappa B Proteins |
650 | 0 | 4 | _aKinetics |
650 | 0 | 4 |
_aN-Methylaspartate _xpharmacology |
650 | 0 | 4 | _aNF-KappaB Inhibitor alpha |
650 | 0 | 4 |
_aNF-kappa B _xantagonists & inhibitors |
650 | 0 | 4 |
_aNeurons _xcytology |
650 | 0 | 4 |
_aOligodeoxyribonucleotides _xchemistry |
650 | 0 | 4 | _aPhosphorylation |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aReceptors, N-Methyl-D-Aspartate _xdrug effects |
700 | 1 | _aXu, K | |
700 | 1 | _aZhu, D | |
700 | 1 | _aKelly, C | |
700 | 1 | _aTerhakopian, A | |
700 | 1 | _aNovelli, A | |
700 | 1 | _aMarini, A M | |
773 | 0 |
_tJournal of neurochemistry _gvol. 78 _gno. 2 _gp. 254-64 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1046/j.1471-4159.2001.00386.x _zAvailable from publisher's website |
999 |
_c11389930 _d11389930 |